Complaints evaluation and handling, Investigation and Determination, CAPA and Return and Recall of products in Quality Management system in pharmaceutical or any industry.
The document provides standard operating procedures (SOPs) for handling complaints and recalls at a pharmaceutical company. It defines complaints, outlines the need for a complaint handling system, and describes procedures for receiving, investigating, and responding to complaints within defined timelines. It also provides templates for documenting complaint investigations and reports. The document similarly describes procedures for identifying, evaluating, and executing a recall of defective medical products in compliance with regulatory authorities.
Role of quality system and audits in pharmamaceuticalganpat420
油
Introduction
cGMP Regulations
Quality Assurance Function
Quality Systems Approach
Management Responsibilities
Resources
Manufacturing Operations
Evaluation Activities
Transitioning to Quality Systems Approach
Audit Checklist for Drug Industry
This document discusses vendor qualification and product returns and recalls in the pharmaceutical industry. It provides definitions and guidelines for recall classification, initiation, and responsibilities of recalling firms. It also discusses vendor qualification categories and criteria for selection. The key points are that recall means removing violating products from the market, while return means sending unused products back. Firms must qualify vendors on various criteria like quality, delivery, and facilities to ensure consistent product quality.
This document discusses a six system inspection model for quality management in pharmaceutical manufacturing. It describes each of the six systems - quality system, production system, facilities and equipment system, laboratory control system, materials system, and packaging and labeling system. For each system, it outlines the key aspects and cites the relevant cGMP regulations. It emphasizes that the six systems are interrelated and must work together to ensure quality control and compliance with regulations. Regular self-inspections are also highlighted as an important part of pharmaceutical quality management.
This document discusses batch manufacturing records (BMRs), which are necessary quality and GMP documentation used to trace the complete manufacturing cycle of a batch or lot of a product. A BMR contains information about the batch including the batch number, size, composition, manufacturing record, weight of drug, shelf life, and storage conditions. It also includes general manufacturing instructions, a cleaning record of equipment used, a bill of materials listing raw materials, step-by-step manufacturing process details, yield calculations, a list of abbreviations, and a history of changes made to the document. A good BMR format contains all of this essential information.
cGMP Guidelines According to Schedule MANKUSH JADHAV
油
This document provides an overview of cGMP guidelines according to Schedule M. It defines cGMP and outlines key areas that must be addressed including personnel, premises, equipment, standard operating procedures, raw materials, self inspections, master formula records, batch manufacturing records, warehousing, and validation. The guidelines ensure quality products are consistently produced and that quality is built into every step of the manufacturing process.
This document discusses concepts of change control, out of specifications (OOS), and out of trends (OOT) in pharmaceutical quality assurance. It defines change control as a procedure to review, verify, regulate, manage, approve and control changes made to systems or processes. OOS refers to test results that fall outside pre-defined acceptance criteria, while OOT describes results that do not follow expected trends. The document outlines procedures for investigating and managing changes, OOS, and OOT to ensure product quality and compliance with regulations.
The document discusses current Good Manufacturing Practices (cGMP) according to the US Food and Drug Administration (FDA). It provides an overview of cGMP principles and requirements, including proper facilities and equipment design, documentation practices, and quality control. The document also summarizes key cGMP regulations and guidelines for manufacturing, processing, packaging, holding, testing, and distributing drug products. It outlines the important documents, facilities, equipment, production processes, and quality systems that must be in place to ensure consistent production of safe, effective pharmaceuticals.
The document discusses product complaints and recalls in the pharmaceutical industry. It defines a complaint as customer dissatisfaction about a product and outlines four types of complaints. It details the four-step process of handling complaints, which includes receiving, investigating, implementing corrective actions, and reporting. The document also defines a recall as removing a product from distribution due to quality, safety or efficacy issues. It describes the reasons and types of recalls, as well as the classification, levels and timelines involved in an effective recall system.
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
油
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved speci鍖cations, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product s manufacturing sequence.
The document discusses the pharmaceutical industry development process in India. It outlines the legal requirements and licenses needed to manufacture or import APIs and drugs. Companies must seek approval from the DCGI and adhere to CDSCO guidelines. The application process requires submitting chemical, pharmaceutical, pre-clinical and clinical data. Various forms are used for obtaining manufacturing, import, and sales licenses from the CDSCO. The CDSCO-SUGAM project aims to streamline approval processes.
The document discusses Good Manufacturing Practices (GMP) for distribution, distribution records, handling returned goods, and recovery/reprocessing of materials. It provides guidelines for distribution procedures including first expiration, first out (FEFO) and batch recall systems. It also outlines requirements for distribution records, handling returned products, and reprocessing materials to ensure quality is maintained.
The document discusses batch manufacturing records (BMRs) and master formula records (MFRs) for pharmaceutical products. It notes that BMRs should include complete information about manufacturing and quality control for each batch, and that line clearance is important before starting a new batch to ensure all remnants of the previous batch are removed. MFRs should provide detailed instructions for each product and batch size. Both BMRs and MFRs are important quality documentation that allow for full traceability of the manufacturing process.
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGESganpat420
油
Abstract
Introduction
Global pharmaceutical industry
Indian pharmaceutical industry
Indian Pharmaceutical Market
Opportunities
Challenges
Conclusion
References
Purchase specifications & Maintenance of stores For Raw materialsYash Menghani
油
This document discusses the purchase specifications and maintenance of stores for raw materials. It defines raw materials as all materials used in manufacturing finished products. Purchase specifications provide guidelines that define operational, physical and chemical characteristics and quality of items to be acquired. Maintaining proper stores is important, requiring inspection centers, storage at appropriate temperatures, and clear labeling of materials with names, batch numbers, and expiration/retesting dates.
The document is a presentation on post-approval changes to bulk active chemicals. It discusses FDA guidance called BACPAC (Bulk Active Chemicals & Post Approval Changes) which provides recommendations for post-approval changes to drug substance synthesis, including site, scale and equipment changes as well as specification and manufacturing process changes. The guidance covers assessing equivalence after changes and determining the appropriate reporting category based on the potential effects of changes.
CGMP guidelines, CFR, CDER and CBER, PIC/S, Environment control in pharma industry, plant layout, maintenance of sterile area, Clean room classification, Environmental monitoring, Types of contaminants in pharma industry & Good Warehousing Practices.
Documentation of technology Transfer .pptxParthRana47
油
This document outlines the various protocols and reports required for technology transfer between pharmaceutical companies. It discusses confidentiality agreements, licensing, research and development reports, technology transfer plans, process validation protocols, equipment and facility qualification protocols, cleaning validation protocols, and analytical methods transfer protocols. The goal of technology transfer is to ensure that manufacturing capabilities, methods, and intellectual property are effectively transferred between parties in a controlled and documented manner.
ICH Q10 provides a harmonized model for a pharmaceutical quality system throughout the lifecycle of a product. It describes a quality management system for the pharmaceutical industry. The objectives of the Q10 model are to achieve product realization, establish and maintain a state of control, and facilitate continual improvement. ICH Q10 covers pharmaceutical development, technology transfer, commercial manufacturing, and product discontinuation. It is intended to enhance existing good manufacturing practice requirements and be used together with them.
Quality Audit in pharmaceutical industryHari Haran
油
It deals with the understanding and process for auditing
pharmaceutical industries. This covers the methodology involved in auditing process of different in pharmaceutical industries.
AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT HemlataMore3
油
This document discusses auditing of quality assurance and engineering departments. It defines quality audit and discusses the importance of quality maintenance through pillars such as focused improvement and autonomous maintenance. Critical systems like HVAC, WFI, and ETP are explained. HVAC is described as maintaining temperature and air flow. Validation of HVAC, WFI, and ETP systems is outlined. The document provides references for further information.
Documentation is an integral part of good manufacturing practices. It defines a system of information and control so that risks so inherent in misinterpretation and/or error in oral communication are minimized.
This document discusses product complaints and recalls. It defines a complaint as any expression of dissatisfaction with a product. Complaints can come internally from production or quality control or externally from customers. Complaints are classified as critical, major, or minor depending on their severity and health risks. The document outlines guidelines for designating a person to handle complaints, investigating complaints, providing corrective actions and feedback, and analyzing complaint trends. It also defines and discusses the types and procedures for product recalls when serious quality issues are found.
The document discusses current Good Manufacturing Practices (cGMP) according to the US Food and Drug Administration (FDA). It provides an overview of cGMP principles and requirements, including proper facilities and equipment design, documentation practices, and quality control. The document also summarizes key cGMP regulations and guidelines for manufacturing, processing, packaging, holding, testing, and distributing drug products. It outlines the important documents, facilities, equipment, production processes, and quality systems that must be in place to ensure consistent production of safe, effective pharmaceuticals.
The document discusses product complaints and recalls in the pharmaceutical industry. It defines a complaint as customer dissatisfaction about a product and outlines four types of complaints. It details the four-step process of handling complaints, which includes receiving, investigating, implementing corrective actions, and reporting. The document also defines a recall as removing a product from distribution due to quality, safety or efficacy issues. It describes the reasons and types of recalls, as well as the classification, levels and timelines involved in an effective recall system.
Role of quality systems and audits in pharmaceutical manufacturing environmentMalay Pandya
油
By regulation, appropriate practice, and common sense, quality assurance (QA) is a critical function in the pharmaceutical manufacturing environment. The need for an independent unit to audit and comment on the appropriate application of standard operating procedures, master batch records, procedures approved in product applications, and the proper functioning of the quality control (QC) unit is paramount.
This helps assure that products are manufactured reliably, with adherence to approved speci鍖cations, and that current good manufacturing practices (cGMP) are maintained in conformance to regulation, both in the facility in general and the microenvironment of each product s manufacturing sequence.
The document discusses the pharmaceutical industry development process in India. It outlines the legal requirements and licenses needed to manufacture or import APIs and drugs. Companies must seek approval from the DCGI and adhere to CDSCO guidelines. The application process requires submitting chemical, pharmaceutical, pre-clinical and clinical data. Various forms are used for obtaining manufacturing, import, and sales licenses from the CDSCO. The CDSCO-SUGAM project aims to streamline approval processes.
The document discusses Good Manufacturing Practices (GMP) for distribution, distribution records, handling returned goods, and recovery/reprocessing of materials. It provides guidelines for distribution procedures including first expiration, first out (FEFO) and batch recall systems. It also outlines requirements for distribution records, handling returned products, and reprocessing materials to ensure quality is maintained.
The document discusses batch manufacturing records (BMRs) and master formula records (MFRs) for pharmaceutical products. It notes that BMRs should include complete information about manufacturing and quality control for each batch, and that line clearance is important before starting a new batch to ensure all remnants of the previous batch are removed. MFRs should provide detailed instructions for each product and batch size. Both BMRs and MFRs are important quality documentation that allow for full traceability of the manufacturing process.
NEW ERA OF DRUG PRODUCT: OPPORTUNITIES AND CHALLENGESganpat420
油
Abstract
Introduction
Global pharmaceutical industry
Indian pharmaceutical industry
Indian Pharmaceutical Market
Opportunities
Challenges
Conclusion
References
Purchase specifications & Maintenance of stores For Raw materialsYash Menghani
油
This document discusses the purchase specifications and maintenance of stores for raw materials. It defines raw materials as all materials used in manufacturing finished products. Purchase specifications provide guidelines that define operational, physical and chemical characteristics and quality of items to be acquired. Maintaining proper stores is important, requiring inspection centers, storage at appropriate temperatures, and clear labeling of materials with names, batch numbers, and expiration/retesting dates.
The document is a presentation on post-approval changes to bulk active chemicals. It discusses FDA guidance called BACPAC (Bulk Active Chemicals & Post Approval Changes) which provides recommendations for post-approval changes to drug substance synthesis, including site, scale and equipment changes as well as specification and manufacturing process changes. The guidance covers assessing equivalence after changes and determining the appropriate reporting category based on the potential effects of changes.
CGMP guidelines, CFR, CDER and CBER, PIC/S, Environment control in pharma industry, plant layout, maintenance of sterile area, Clean room classification, Environmental monitoring, Types of contaminants in pharma industry & Good Warehousing Practices.
Documentation of technology Transfer .pptxParthRana47
油
This document outlines the various protocols and reports required for technology transfer between pharmaceutical companies. It discusses confidentiality agreements, licensing, research and development reports, technology transfer plans, process validation protocols, equipment and facility qualification protocols, cleaning validation protocols, and analytical methods transfer protocols. The goal of technology transfer is to ensure that manufacturing capabilities, methods, and intellectual property are effectively transferred between parties in a controlled and documented manner.
ICH Q10 provides a harmonized model for a pharmaceutical quality system throughout the lifecycle of a product. It describes a quality management system for the pharmaceutical industry. The objectives of the Q10 model are to achieve product realization, establish and maintain a state of control, and facilitate continual improvement. ICH Q10 covers pharmaceutical development, technology transfer, commercial manufacturing, and product discontinuation. It is intended to enhance existing good manufacturing practice requirements and be used together with them.
Quality Audit in pharmaceutical industryHari Haran
油
It deals with the understanding and process for auditing
pharmaceutical industries. This covers the methodology involved in auditing process of different in pharmaceutical industries.
AUDITING OF AUALITY ASSURANCE AND ENGINEERING DEPARTMENT HemlataMore3
油
This document discusses auditing of quality assurance and engineering departments. It defines quality audit and discusses the importance of quality maintenance through pillars such as focused improvement and autonomous maintenance. Critical systems like HVAC, WFI, and ETP are explained. HVAC is described as maintaining temperature and air flow. Validation of HVAC, WFI, and ETP systems is outlined. The document provides references for further information.
Documentation is an integral part of good manufacturing practices. It defines a system of information and control so that risks so inherent in misinterpretation and/or error in oral communication are minimized.
This document discusses product complaints and recalls. It defines a complaint as any expression of dissatisfaction with a product. Complaints can come internally from production or quality control or externally from customers. Complaints are classified as critical, major, or minor depending on their severity and health risks. The document outlines guidelines for designating a person to handle complaints, investigating complaints, providing corrective actions and feedback, and analyzing complaint trends. It also defines and discusses the types and procedures for product recalls when serious quality issues are found.
COMPLAINTS
TOPIC COVERED
1.Definition
2.Principle
3.Need for complaint handling system
4.Objectives
5.Responsibility
6.Type of complaints (CRITICAL,MAJOR ,MINOR)
7.Key for handling complaint
8.Content of product complaint data sheet
9.Steps involved in handling of complaint
10.Recordings of complain
B PHARAM 6TH SEM
PHARAMACEUTICAL QUALITY ASSURANCE
COMPLAINT
Reasons
Types of Complaint
Steps involved in Handling of complaints
Product Complaint Data Sheet
Complaint Record
Regulatory Guidelines
SOP on Complaint Handling
RECALL
Reasons
Types of Recall
Recall Classification
Levels of Recall
How to Recall the Product?
How To Notify The Consumers?
Regulatory Guidelines
SOP on Product Recall
DRUG RECALL IN 2013 AND 2014
This document discusses product complaint handling procedures. It defines a complaint and provides reasons for having a complaint handling process. It describes the types of complaints that may occur and the steps involved in handling complaints which include receiving the complaint, investigating it technically and through documentation, determining if it is confirmed or not, taking corrective actions and feedback to customers, and performing monthly reporting and trend analysis. It also discusses regulatory guidelines around complaint handling and provides an example standard operating procedure on complaint handling.
The document discusses complaint handling and product recalls in pharmaceutical companies. It defines a complaint as an expression of customer dissatisfaction and explains the need for an effective complaint handling system to improve quality, maintain regulatory compliance and build customer relationships. It outlines the objectives, responsibilities and types of complaints, as well as the steps to handle complaints which include receiving, investigating, implementing corrective actions, providing feedback and reporting. The document also defines and discusses the objectives, classification, strategy and procedures for conducting an effective product recall.
A COMPLETE STUDY ON COMPLAINTS, DRUG RECALL, RETURNED PRODUCTS, AND WASTE DIS...Teny Thomas
油
a detailed study on complaints, drug recall, returned goods and waste disposal is studied here in the presentation for the students of sixthe semester b.pharm following the PCI syllabus.
1. The document discusses procedures for handling complaints and product recalls in the pharmaceutical industry. It defines complaints, outlines standard operating procedures for complaint handling, investigation and corrective actions.
2. Recall procedures include classification of recalls based on health hazards, forming a recall team, developing a recall strategy, notifying customers, and terminating a recall once all affected products are removed from the market.
3. Key aspects of complaint handling covered are documentation of complaints, investigating complaints by analyzing customer and retained samples, determining if complaints are confirmed or non-confirmed, and providing feedback to customers.
This document outlines the process for handling pharmaceutical product complaints. It defines a complaint and discusses the need for proper complaint handling procedures. It classifies complaints as critical, major, or minor and describes the 4 main steps to handling complaints: receiving complaints, technical investigation, corrective and preventive actions/feedback, and trend analysis/reporting. Key aspects of each step like documentation, sampling, testing, reporting, and record keeping are described. Regulatory guidelines for complaint management are also provided.
The document discusses complaints procedures for pharmaceutical products. It defines complaints, lists types of complaints (critical, major, minor), and sources of complaints (internal, external, verbal, written). It outlines the steps to evaluate complaints - receiving, investigating, root cause analysis, handling, and recording. Key aspects covered are types of investigations, corrective actions, feedback to customers, monthly reporting and trend analysis, handling returned goods, and recall procedures.
A Detailed Study on Pharmaceutical Drug RecallTeny Thomas
油
1. A drug recall is a process of removing a pharmaceutical product from distribution due to defects, adverse reactions, or counterfeiting concerns.
2. The objectives of a drug recall are to stop distribution and sale of the affected product, notify relevant parties, efficiently remove the product, and implement corrective actions to prevent future recalls.
3. Recalls are classified by the CDSCO as Class I, II, or III depending on the health risks posed by the defective product. A recall strategy and team must be in place to effectively execute any necessary recalls.
1. A drug recall is a process of withdrawing a pharmaceutical product from distribution due to defects, adverse reactions, or counterfeiting concerns. The recall can be initiated by the manufacturer or regulatory authorities.
2. The objectives of a drug recall are to stop distribution of the affected product, notify relevant parties, remove the product from the marketplace, analyze the root cause, and implement corrective actions to prevent future recalls.
3. Recalls are classified by the CDSCO as Class I, II, or III based on the health risk posed by the defective product, with Class I posing the greatest risk requiring the fastest response.
This document discusses types of complaints regarding pharmaceutical products and the procedures for handling complaints and conducting product recalls. There are three main types of complaints: quality complaints, adverse reaction complaints, and other medically related complaints. All complaints should be documented in writing. Quality complaints are handled by quality control, while adverse reactions are reviewed by medical experts. Recalls are conducted when a product's quality is in question, with three degrees of recall depending on health risk. Procedures and documentation are required for complaint handling and recalls. Returned products must be properly stored, examined, and either reprocessed, destroyed, or have their disposition documented.
1. Returned goods and recovered materials from pharmaceutical products need to be evaluated and may be reprocessed, retested, repackaged and resold if they meet specifications.
2. Complaint handling procedures include classifying, investigating, reporting on complaints, maintaining records for regulatory compliance and continual improvement.
3. The complaint handling process involves receiving complaints, conducting a technical investigation which includes documentation review and laboratory analysis, determining corrective actions, and reporting trends to management.
This document discusses pharmaceutical quality assurance processes related to complaints and recalls. It defines a complaint and outlines the need for an effective complaint handling system. It describes how to evaluate complaints, including designating a person to handle complaints and maintaining proper records. Returned goods are also discussed, including how to classify, handle, and make decisions regarding returned products. The document then covers recall procedures, including classification of recalls and the recall process. It provides templates for recall documentation. Finally, it addresses proper waste disposal procedures for rejects and leftovers from production.
1. The document outlines the standard operating procedure (SOP) for handling product complaints at a pharmaceutical company. It describes the process for receiving, investigating, taking corrective actions for complaints, and generating monthly reports.
2. Key aspects of the SOP include categorizing complaints, timelines for investigation, using a product complaint data sheet to document details, conducting documentation-based and laboratory investigations, and providing feedback and corrective actions to customers.
3. Monthly reports analyze complaint trends to assess quantities and types of complaints received. This allows the company to improve product quality and maintain good customer relationships.
How to Configure Restaurants in Odoo 17 Point of SaleCeline George
油
Odoo, a versatile and integrated business management software, excels with its robust Point of Sale (POS) module. This guide delves into the intricacies of configuring restaurants in Odoo 17 POS, unlocking numerous possibilities for streamlined operations and enhanced customer experiences.
Mate, a short story by Kate Grenvile.pptxLiny Jenifer
油
A powerpoint presentation on the short story Mate by Kate Greenville. This presentation provides information on Kate Greenville, a character list, plot summary and critical analysis of the short story.
Prelims of Kaun TALHA : a Travel, Architecture, Lifestyle, Heritage and Activism quiz, organized by Conquiztadors, the Quiz society of Sri Venkateswara College under their annual quizzing fest El Dorado 2025.
Finals of Rass MELAI : a Music, Entertainment, Literature, Arts and Internet Culture Quiz organized by Conquiztadors, the Quiz society of Sri Venkateswara College under their annual quizzing fest El Dorado 2025.
How to Modify Existing Web Pages in Odoo 18Celine George
油
In this slide, well discuss on how to modify existing web pages in Odoo 18. Web pages in Odoo 18 can also gather user data through user-friendly forms, encourage interaction through engaging features.
How to Setup WhatsApp in Odoo 17 - Odoo 際際滷sCeline George
油
Integrate WhatsApp into Odoo using the WhatsApp Business API or third-party modules to enhance communication. This integration enables automated messaging and customer interaction management within Odoo 17.
Computer Application in Business (commerce)Sudar Sudar
油
The main objectives
1. To introduce the concept of computer and its various parts. 2. To explain the concept of data base management system and Management information system.
3. To provide insight about networking and basics of internet
Recall various terms of computer and its part
Understand the meaning of software, operating system, programming language and its features
Comparing Data Vs Information and its management system Understanding about various concepts of management information system
Explain about networking and elements based on internet
1. Recall the various concepts relating to computer and its various parts
2 Understand the meaning of softwares, operating system etc
3 Understanding the meaning and utility of database management system
4 Evaluate the various aspects of management information system
5 Generating more ideas regarding the use of internet for business purpose
How to Configure Flexible Working Schedule in Odoo 18 EmployeeCeline George
油
In this slide, well discuss on how to configure flexible working schedule in Odoo 18 Employee module. In Odoo 18, the Employee module offers powerful tools to configure and manage flexible working schedules tailored to your organization's needs.
Research & Research Methods: Basic Concepts and Types.pptxDr. Sarita Anand
油
This ppt has been made for the students pursuing PG in social science and humanities like M.Ed., M.A. (Education), Ph.D. Scholars. It will be also beneficial for the teachers and other faculty members interested in research and teaching research concepts.
Database population in Odoo 18 - Odoo slidesCeline George
油
In this slide, well discuss the database population in Odoo 18. In Odoo, performance analysis of the source code is more important. Database population is one of the methods used to analyze the performance of our code.
Prelims of Rass MELAI : a Music, Entertainment, Literature, Arts and Internet Culture Quiz organized by Conquiztadors, the Quiz society of Sri Venkateswara College under their annual quizzing fest El Dorado 2025.
How to use Init Hooks in Odoo 18 - Odoo 際際滷sCeline George
油
In this slide, well discuss on how to use Init Hooks in Odoo 18. In Odoo, Init Hooks are essential functions specified as strings in the __init__ file of a module.
Computer Network Unit IV - Lecture Notes - Network LayerMurugan146644
油
Title:
Lecture Notes - Unit IV - The Network Layer
Description:
Welcome to the comprehensive guide on Computer Network concepts, tailored for final year B.Sc. Computer Science students affiliated with Alagappa University. This document covers fundamental principles and advanced topics in Computer Network. PDF content is prepared from the text book Computer Network by Andrew S. Tenanbaum
Key Topics Covered:
Main Topic : The Network Layer
Sub-Topic : Network Layer Design Issues (Store and forward packet switching , service provided to the transport layer, implementation of connection less service, implementation of connection oriented service, Comparision of virtual circuit and datagram subnet), Routing algorithms (Shortest path routing, Flooding , Distance Vector routing algorithm, Link state routing algorithm , hierarchical routing algorithm, broadcast routing, multicast routing algorithm)
Other Link :
1.Introduction to computer network - /slideshow/lecture-notes-introduction-to-computer-network/274183454
2. Physical Layer - /slideshow/lecture-notes-unit-ii-the-physical-layer/274747125
3. Data Link Layer Part 1 : /slideshow/lecture-notes-unit-iii-the-datalink-layer/275288798
Target Audience:
Final year B.Sc. Computer Science students at Alagappa University seeking a solid foundation in Computer Network principles for academic.
About the Author:
Dr. S. Murugan is Associate Professor at Alagappa Government Arts College, Karaikudi. With 23 years of teaching experience in the field of Computer Science, Dr. S. Murugan has a passion for simplifying complex concepts in Computer Network
Disclaimer:
This document is intended for educational purposes only. The content presented here reflects the authors understanding in the field of Computer Network
Computer Network Unit IV - Lecture Notes - Network LayerMurugan146644
油
Complaints in Quality Management System
1. COMPLAINTS
Presented by - Mayuri M. More
Department - QAT(F.Y.M.Pharm.)
Subject - QMS
Modern College of Pharmacy (For ladies) Moshi,pune.
2. CONTENTS -
Complaints
Evaluation and handling
Investigation and Determination
Corrective And Preventive Action
Returns And Recall
3. Complaints -
A statement that is something wrong or not g
ood enough,which show customer dissatisfa
ction about the company and the product.
Reason -
It gives the company an opportunity to impr
ove the quality of products.
It is helpful to maintain CGMP.
Improve safety and performance of device.
5. Types Of Complaints -
1. Quality Complaints - Originate at customer
level and concerned with physical,chemical
and biological properties of products.
2. Adverse Reaction Complaints - Due to all
ergic reaction or fatal reaction.
3. Other Medically Related Complaints - Inc
lude Complaints such as lack of efficacy or
clinical response.
6. Steps Involved In Handling Of Complaints -
Step1: Receiving Complaints - It is important t
o have a open channel with customer in order t
o receive their suggestions, doubts and complai
nts.Generally these channels are toll-free numb
er,e-mails ,chat rooms and P.O. box.
Step2: Technical Investigation -Upon receipt
of the investigation form the QA unit is able to st
art the investigation,which can be devided in tw
o phases.
7. 1. Documentation Based - Checking if this com
plaint occurred previously in the same lot.
2. Laboratory Analysis Phase - Requesting Q
C laboratory to analyze both (Complaints and
retained). If the customer did not send the co
mplaint sample for analysis the lab.Investigati
on will be carried out only with the retained.
Cont...
8. Step3: Corrective And Preventive Action
-
Corrective Action - Action taken to prevent rec
urrence of a non-conformance. Action taken after
the task.
Preventive Action - Action taken to prevent oc
curence of a non-confermance.Action taken befor
e the task.
9. The criteria for choosing appropriate action
depends on the nature of the complaint,and
the complaint insidence.
Step4: Monthaly Report And Trend Analy
sis -
Monthly Report should be elaborated in order t
o evaluate the amount and nature of Complaint
s.
Cont...
10. Monthaly Report must answers the f
ollowing questions -
How many Complaints did the company r
ecieved in period?
How many were confirmed?
How many were not confirmed?
Cont...
11. RETURNED -
Distributed finished products can be returned
for various reasons. These can be for substan
dard quality, damage of packaging, stability re
lated issues; or any other such reasons.
Regulatory Guidelines are available to h
andle such issues -
Product returned from market shall be iden
tified, and stored securely.
A finished Pharmaceutical
12. Cont...
meets appropriate standards, specifications,
and characteristics.
Record of returned drug product shall be
maintained and shall include the following:
The name and label potency of the drug pr
oduct dosage form.
Lot/control/batch number of the drug prod
uct.
Reason for return.
Quantity returned.
13. Cont...
Date of disposition.
Ultimate disposition of returned drug pro
ducts.
Documents Required -
1. SOP on handling returned drug products.
2. Records of returned drug products includi
ng action taken on it and associated batch
es if any.
14. Recall -
Recall is an Action to withdraw /remove the dr
ug from distribution or use by manufacturer for
various reasons.
Ex: substandard quality detected after the pro
duct was distributed.
Damage of product during transit.
Recall applies a;
1. Total ban or permanent removal.
2. Temporary ban or temporary removal.
15. Reason -
FDA authorities may order a Recall
for substandard quality of the finish
ed product.
Accidental damage occurs during tr
ansportation.
Problems related stability.
Types of Recalls -
1. Compulsory Product Recall - In
dustry do not take responsibility.
16. Cont...
2.Voluntarily Product Recall - Industry v
oluntarily recall products.
Time Line for Recall -
I. For class1: within 24 hours upto a maxi
mum 72 hours.
II. For class2: Recall upto a maximum of 1
0 days.
III. For class3: Recall upto a maximum of 3
0 days is allowed.